Study to Evaluate an 8 mg Aflibercept (EYLEA®) Prefilled Syringe (PFS)

Clinical trial NCT05989126 · COMPLETED

Trial details

NCT number: NCT05989126
Sponsor: Regeneron Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetic Macular Edema (DME)Neovascular Age-Related Macular Degeneration (nAMD)

Start date: 2024-04-15
Primary completion: 2024-05-31
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.